PharmaCore Labs

PharmaCore Labs is a private China-based drug discovery services company focused on ion channel biology and preclinical cardiac safety assessment. The company has described itself as a Chinese-foreign joint venture founded in 2013 and based in Haimen, Jiangsu Province, with branch offices in Shanghai and New York. Its offerings center on ion channel drug discovery, cardiac liability testing, and related preclinical support for pharmaceutical research clients, and it has been positioned as a partner within broader oncology and discovery service networks. PharmaCore Labs has also been cited as a partner of Reaction Biology for China outreach and as a contributor of cardiac safety and ion channel capabilities within the Reaction Oncology Platform. Based on available public information, it appears to operate primarily as a CRO/service provider rather than as a therapeutic product developer with a disclosed clinical pipeline.